Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 6

1.

Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease.

Abdelmalek MF, Suzuki A, Guy C, Unalp-Arida A, Colvin R, Johnson RJ, Diehl AM; Nonalcoholic Steatohepatitis Clinical Research Network.

Hepatology. 2010 Jun;51(6):1961-71. doi: 10.1002/hep.23535.

2.

Fructose consumption as a risk factor for non-alcoholic fatty liver disease.

Ouyang X, Cirillo P, Sautin Y, McCall S, Bruchette JL, Diehl AM, Johnson RJ, Abdelmalek MF.

J Hepatol. 2008 Jun;48(6):993-9. doi: 10.1016/j.jhep.2008.02.011. Epub 2008 Mar 10.

3.

Study of human liver disease with P-31 magnetic resonance spectroscopy.

Oberhaensli R, Rajagopalan B, Galloway GJ, Taylor DJ, Radda GK.

Gut. 1990 Apr;31(4):463-7.

4.

Fructose-induced aberration of metabolism in familial gout identified by 31P magnetic resonance spectroscopy.

Seegmiller JE, Dixon RM, Kemp GJ, Angus PW, McAlindon TE, Dieppe P, Rajagopalan B, Radda GK.

Proc Natl Acad Sci U S A. 1990 Nov;87(21):8326-30.

6.

ATP depletion, a possible role in the pathogenesis of hyperuricemia in glycogen storage disease type I.

Greene HL, Wilson FA, Hefferan P, Terry AB, Moran JR, Slonim AE, Claus TH, Burr IM.

J Clin Invest. 1978 Aug;62(2):321-8.

Supplemental Content

Support Center